
The Virginia Cannabis Control Authority reported data on medical cannabis sales and most popular products for July to August 2025.

The Virginia Cannabis Control Authority reported data on medical cannabis sales and most popular products for July to August 2025.

Green Thumb Industries' RISE Dispensaries celebrates the launch of adult-use cannabis in Minnesota with new products and donations.

Our top five cannabis and hemp news this week: OCM fines NY lab, Congress halts rescheduling funding, Texas issues hemp order, NJ supports businesses with $15M in funding, and our latest podcast episode.

Governor Tim Walz signs new cannabis compact with Mille Lacs Band of Ojibwe, a move to regulate the market and support the start of Minnesota adult-use sales.

A UK Medical Cannabis Registry study found cannabis-based medicines improved sleep, anxiety, and quality of life in insomnia patients.

Test your knowledge of cannabis compliance in 2025. This quiz covers key issues like cross-state expansion and FDA oversight.

According to the Division of Cannabis Control, medical marijuana sales exceeded $2.2 billion and recreational cannabis generated over $785 million since legalization.

New Jersey’s new NJ LEAF program provides up to $1.5M in flexible funding to help cannabis businesses overcome capital access gaps.

Clinical and in vitro analysis shows THC may impair female fertility, distrupting oocyte development and affecting IVF outcomes.

New York's cannabis industry has grown to over $2 billion. The OCM's update shows market rebound and new support for equity applicants.

The FY26 CJS Appropriations Act includes Section 607, barring cannabis rescheduling. Advocates warn the Act threatens medical cannabis protections.

The OCM is taking action against Lexachrom Laboratory for regulatory failures and significant violations, jeopardizing consumer safety and market integrity.

The Texas Cannabis Policy Center and Texas Hemp Business Council both support Governor Abbott’s executive order on hemp regulations.

Our top five cannabis and hemp news this week: Nebraska’s medical cannabis battle, rescheduling debate, Thailand policy shifts, new medical cannabis research, and pricing trends.

This month’s Healer webinar, led by Dustin Sulak, DO, explores new medical cannabis research including potential benefits for cancer, wound healing, ALS, Alzheimer’s, and terpenes like alpha-pinene.

Texas Governor Greg Abbott issues an executive order to regulate product sales, requiring ID checks and testing.

New York's legal cannabis sales top $2 billion, with 46 new licenses approved. The state is prioritizing social equity and new education panels.

In this interview, Steve Allin, director of the International Hemp Building Association shares insights on the versatility and benefits of hemp as a crop and as a material used in construction.

Thailand's cannabis laws are evolving. A new Prime Minister brings hope for a discussion on legalizing cannabis.

An examination of survey data finds state cannabis laws strongly shape delta-8-THC use, with highest rates in prohibition states.

What's driving the cannabis pricing crisis? Test your knowledge regarding the market forces and trends that are reshaping the industry for 2025.

Citing risks to children, health, and public safety, nine Congress members sent a letter to Attorney General Pam Bondi and President Donald Trump, opposing the rescheduling of cannabis.

The Maryland Comptroller reports nearly $18.4 million in Q2 cannabis tax revenue. The Central region, including Baltimore, generated the most income.

Nebraska’s cannabis commission approves restrictive rules, limiting patient access and business licenses.

Here, we bring you our top five recent articles covering federal hemp ban, an interview with Reginald Gaudino, PhD, the reintroduced MORE Act, Delaware cannabis sales and rezoning, and restricting intoxicating hemp-derived cannabinoids.

Recent research highlights the potential of cannabinoids as alternative treatments for atopic dermatitis, showcasing their anti-inflammatory and antibacterial properties.

Delaware's first month of recreational marijuana sales was a success at over $7 million, but the veto of SB 75 shows an ongoing zoning debate.

The organization voiced its support of Texas and other states restricting synthetic hemp cannabinoids, urging science-based regulation to protect consumers, businesses, and public safety.

THC drinks are shaping a new drinking culture. A recent report dives into market growth, state regulations, and the challenges facing the industry.

The MORE Act, a federal cannabis reform bill, has recently been reintroduced to US Congress, with plans to deschedule cannabis and expunge convictions.